Finance entity
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Brooklyn Investment Group, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.4 in the same window.
Last mentioned: 1d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Brooklyn Investment Group, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.4 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. I-Mab appears in 1 tracked Finance story from August 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering I-Mab. Shared-story counts are live from our verified record — not editorial picks.
Two micro-caps reported late-August earnings: biotech I-Mab posted $(0.16) EPS while CreditRiskMonitor posted $(0.04) EPS on $5.17M revenue. Divergent risk profiles—1.47 beta vs 0.22 beta—highlight small-cap earnings dynamics.
I-Mab is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
